YIBAI PHARMACEUTICAL(SH:600594) Xin Lang Cai Jing·2025-10-30 01:33Core Viewpoint - Yibai Pharmaceutical (600594.SH) reported its Q3 2025 results, indicating a decline in institutional ownership and a stable presence of public funds and foreign investors [1] Institutional Ownership - As of October 29, 2025, there is one institutional investor holding shares in Yibai Pharmaceutical, with a total holding of 8.686 million shares, representing 1.10% of the total share capital [1] - The institutional ownership percentage has decreased by 2.31 percentage points compared to the previous quarter [1] Public Fund Participation - In this reporting period, 50 public funds were not disclosed compared to the previous quarter, including notable funds such as Huaxia CSI 500 Index Enhanced A and Wanjiaguo CSI 2000 ETF [1] Foreign Investor Activity - The report indicates that foreign institutions such as BARCLAYS BANK PLC and J.P. Morgan Securities PLC - proprietary funds were not disclosed in this quarter compared to the last [1]